Seattle Genetics

Are Biotech M&A Premiums Already Built In? Valuations Do Matter
Are Biotech M&A Premiums Already Built In? Valuations Do Matter
Seeking Alpha
biotech
M&A
ONYX Pharmaceuticals
Alexion
Biomarin
Incyte
Medivation
Pharmacyclics
Regeneron
Seattle Genetics
Flag link:
Understanding the Massive Market Potential of Monoclonal Antibodies
Understanding the Massive Market Potential of Monoclonal Antibodies
Motley Fool
monoclonal antibodies
Roche
Herceptin
Rituxan
Avastin
GSK
Amgen
Eli Lilly
Bristol-Myers Squibb
Seattle Genetics
Adcetris
Kadcyla
bapineuzumab
Elan
JNJ
Pfizer
necitumumab
AbbVie
Humira
Flag link:
These biotech names are ripe for takeover: Cramer
These biotech names are ripe for takeover: Cramer
CNBC
M&A
Amgen
ONYX Pharmaceuticals
Medivation
Astellas
Seattle Genetics
Flag link:
Biotech Buyouts: Who's Next?
Biotech Buyouts: Who's Next?
Motley Fool
M&A
ONYX Pharmaceuticals
Amgen
Seattle Genetics
Medivation
Incyte
Flag link:
Seattle Genetics, Astellas affiliate announce co-development of added ADC
Seattle Genetics, Astellas affiliate announce co-development of added ADC
The Fly on the Wall
Seattle Genetics
antibody-drug conjugate
Astellas
ASG-15ME
Agensys
bladder cancer
lung cancer
Flag link:
Safety Concern Halts Study of Seattle Genetics' Lymphoma Drug
Safety Concern Halts Study of Seattle Genetics' Lymphoma Drug
TheStreet.com
Seattle Genetics
Adcetris
Hodgkin's lymphoma
Flag link:
Seattle Genetics, Bayer to Develop Less Symptomatic Cancer Drug
Seattle Genetics, Bayer to Develop Less Symptomatic Cancer Drug
FOX Business
Seattle Genetics
Bayer
antibody-drug conjugate
Flag link:
Seattle Genetics highlights ADCETRIS data at lymphoma conference
Seattle Genetics highlights ADCETRIS data at lymphoma conference
Yahoo/Fly on the Wall
Seattle Genetics
Adcetris
lymphoma
Flag link:
A Trio of Cancer Immunotherapy Innovators
A Trio of Cancer Immunotherapy Innovators
Motley Fool
Immunogen
Seattle Genetics
Celldex
Flag link:
Seattle Genetics Highlights Adcetris (Brentuximab Vedotin) Frontline HL and MTCL Clinical Development Programs and Antibody-Drug Conjugate (ADC) Collaborator Data at ASCO Annual Meeting
Seattle Genetics Highlights Adcetris (Brentuximab Vedotin) Frontline HL and MTCL Clinical Development Programs and Antibody-Drug Conjugate (ADC) Collaborator Data at ASCO Annual Meeting
Yahoo/BusinessWire
Seattle Genetics
Adcetris
T-cell lymphoma
systemic anaplastic large cell lymphoma
Hodgkin's lymphoma
Flag link:
2013 FDA Drug Approval Calendar
2013 FDA Drug Approval Calendar
TheStreet.com
drug approvals
GSK
Dolutegravir
Trametenib
Auxilium
Xiaflex
Delcath
Melblez
Seattle Genetics
Adcetris
Antares
Otrexup
Amag Pharmaceuticals
Feraheme
Cubist Pharmaceuticals
Entereg
Gilead
sofosbuvir
Amarin
Vascepa
Merck
suvorexant
Valeant Pharmaceuticals
efinaconazole
Depomed
Sefelsa
Zogenix
Zohydro
dabrafenib
tivozanib
Aveo Pharmaceuticals
Flag link:
Narrower-than-Expected Loss at Seattle Genetics
Narrower-than-Expected Loss at Seattle Genetics
Yahoo/Zacks
Seattle Genetics
earnings
Flag link:
Declines From Seattle Genetics Inc. (SGEN) Drive Down Health Care Sector
Declines From Seattle Genetics Inc. (SGEN) Drive Down Health Care Sector
TheStreet.com
Seattle Genetics
Flag link:
Anything Can Happen This Year For Celldex
Anything Can Happen This Year For Celldex
Seeking Alpha
Celldex
breast cancer
CDX-110
CDX-111
Seattle Genetics
Flag link:
Five Super Ideas in the Healthcare Sector
Five Super Ideas in the Healthcare Sector
Motley Fool
Eli Lilly
Merck
Forest Labs
Regeneron
Seattle Genetics
Flag link:
Seattle Genetics Initiates Two Phase I Trials of SGN-CD19A
Seattle Genetics Initiates Two Phase I Trials of SGN-CD19A
Yahoo
Seattle Genetics
SGN-CD19A
acute lymphoblastic leukemia
non-Hodgkin B-cell lymphoma
Flag link:
4 Healthcare Stock Stories for TGIF Wellness
4 Healthcare Stock Stories for TGIF Wellness
Wall Street Cheat Street
Vertex Pharmaceuticals
Seattle Genetics
Echo Therapeutics
Santarus
Flag link:
Biotech Portfolio Update: 2012 Summary And 2013 Outlook
Biotech Portfolio Update: 2012 Summary And 2013 Outlook
Seeking Alpha
Arqule
Array Biopharma
Celldex
Aveo Pharmaceutical
Curis
Exelixis
MorphoSys
Genmab
Novartis
Incyte
Seattle Genetics
YM BioSciences
Flag link:
Biotech Corner: Monoclonal Antibody Companies
Biotech Corner: Monoclonal Antibody Companies
Seeking Alpha
monoclonal antibodies
Adcetris
Seattle Genetics
Progenics
Flag link:
Seattle Genetics to test possible new Adcetris use in late-stage study
Seattle Genetics to test possible new Adcetris use in late-stage study
Yahoo/AP
Seattle Genetics
Adcetris
non-Hodgkin's lymphoma
Flag link:

Pages